Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services Research

Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus

  1. Sylvia H. Ley1,2⇑,
  2. Jorge E. Chavarro2,3,4,
  3. Mengying Li5,
  4. Wei Bao6,
  5. Stefanie N. Hinkle5,
  6. Pandora L. Wander7,
  7. Janet Rich-Edwards4,8,
  8. Sjurdur Olsen2,9,
  9. Allan Vaag10,
  10. Peter Damm11,
  11. Louise G. Grunnet12,
  12. James L. Mills5,
  13. Frank B. Hu2,3,4 and
  14. Cuilin Zhang5⇑
  1. 1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA
  2. 2Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
  3. 3Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
  4. 4Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  5. 5Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
  6. 6Department of Epidemiology, University of Iowa, Iowa City, IA
  7. 7Department of Medicine, University of Washington, Seattle, WA
  8. 8Division of Women’s Health, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
  9. 9Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
  10. 10Steno Diabetes Center Copenhagen, Copenhagen, Denmark
  11. 11Department of Obstetrics, Center for Pregnant Women with Diabetes, Rigshospitalet, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  12. 12Department of Endocrinology, Diabetes and Bone-Metabolic Research Unit, Rigshospitalet, Copenhagen, Denmark
  1. Corresponding authors: Cuilin Zhang, zhangcu{at}mail.nih.gov, and Sylvia H. Ley, sley{at}tulane.edu
Diabetes Care 2020 Apr; 43(4): 793-798. https://doi.org/10.2337/dc19-2237
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE We examined the association of lactation duration with incident type 2 diabetes among women with a history of gestational diabetes mellitus (GDM).

RESEARCH DESIGN AND METHODS We monitored 4,372 women with a history of GDM participating in the Nurses’ Health Study II for incident type 2 diabetes over 25 years up to 2017. Lactation history was obtained through follow-up questionnaires to calculate lactation duration. Follow-up blood samples were collected from a subset of these women at median age of 58 years through the Diabetes & Women’s Health Study.

RESULTS We documented 873 incident cases of type 2 diabetes during 87,411 person-years of follow-up. Longer duration of lactation was associated with lower risk of type 2 diabetes for both total lactation (hazard ratio 1.05 [95% CI 0.83–1.34] for up to 6 months, 0.91 [0.72–1.16] for 6–12 months, 0.85 [0.67–1.06] for 12–24 months, and 0.73 [0.57–0.93] for >24 months, compared with 0 months; P-trend = 0.003) and exclusive breastfeeding (P-trend = 0.002) after adjustment for age, ethnicity, family history of diabetes, parity, age at first birth, smoking, diet quality, physical activity, and prepregnancy BMI. Longer duration of lactation was also associated with lower HbA1c, fasting plasma insulin, and C-peptide concentrations among women without type 2 diabetes at follow-up (all adjusted P-trend ≤0.04).

CONCLUSIONS Longer duration of lactation is associated with a lower risk of type 2 diabetes and a favorable glucose metabolic biomarker profile among women with a history of GDM. The underlying mechanisms and impact on diabetes complications, morbidity, and mortality remain to be determined.

Introduction

As women undergo changes in metabolism to meet the demands of the growing fetus and to prepare for delivery and lactation (1), they often experience deterioration in insulin sensitivity during normal pregnancy (2). Although most women maintain glucose homeostasis by a compensatory increase in insulin secretion (1,3), this compensatory mechanism is insufficient in some women, resulting in gestational diabetes mellitus (GDM), which affects ∼5–9% of pregnancies in the U.S. (4,5). Because women with a history of GDM are at higher risk for type 2 diabetes later in life (6,7), it is critical to identify modifiable determinants of type 2 diabetes risk prevention specific for these high-risk women.

Breastfeeding has a potential role in women’s cardiometabolic health (8,9), including type 2 diabetes prevention (10–12). In ongoing large-scale prospective cohorts of >150,000 parous women in the U.S. (13), longer duration of lactation was associated with lower risk for type 2 diabetes later in life. More recent investigations from other prospective studies in the U.S. and Europe demonstrated that the protective association was also evident among women with a history of GDM (14–16). In addition to women with a history of GDM being at a higher risk for type 2 diabetes progression later in life (6,7), women with diabetes during pregnancy experience breastfeeding challenges in early postpartum, including delayed onset of “milk coming in,” also known as lactogenesis II (17). Therefore, targeting breastfeeding has a preventive potential, especially among these high-risk women with a history of GDM.

In addition to larger-scale prospective data, previous short-term investigations have reported the favorable recovery of insulin sensitivity among women who breastfeed in the early postpartum period (18,19). However, data are lacking on the association between lactation duration and biomarkers of glucose metabolism long-term after the index pregnancy. We therefore measured fasting plasma insulin and C-peptide concentrations among middle-aged women with a history of GDM. The objective of this study was to determine the associations of lifetime lactation duration with incident type 2 diabetes risk and biomarkers of glucose metabolism later in life among women with a history of GDM.

Research Design and Methods

Study Population

The Nurses’ Health Study (NHS) II is an on-going prospective cohort of 116,671 female registered nurses from the U.S. aged 25–42 years in 1989. Participants were monitored biennially using validated questionnaires on medical history and lifestyle. NHS II participants were eligible for inclusion in the current study if they reported a history of GDM in 1991 or incident GDM through the biennial questionnaires up to 2001 or through a 2009 pregnancy questionnaire, which inquired about physician diagnoses of GDM. In a review of medical records among 120 women, 94% were confirmed to have a “definite or probable” diagnosis of GDM (20). In a random sample of parous women (n = 100), a high level of GDM surveillance was documented in this cohort, with 83% reporting they underwent a glucose challenge test during pregnancy and 100% reporting frequent prenatal urine screening. Participants were excluded if they reported cancer, cardiovascular disease, or multiple-birth pregnancy before the GDM pregnancy or were missing important data such as lactation information and BMI at age 18 years. We therefore included 4,372 women with a history of GDM. Between 2012 and 2014, the NHS II participants who reported a history of GDM were invited to participate in the Diabetes & Women’s Health (DWH) Study. Details of the DWH study protocol have been published previously (21). Fasting blood samples were collected from 934 women (21), and the baseline characteristics of those who provided blood samples were similar to the entire study population of women with a history of GDM. The current biomarker analysis included DWH study participants in NHS II who were free from type 2 diabetes, defined as hemoglobin A1c (HbA1c) <6.5% (48 mmol/mol) at the follow-up blood collection and who had data on duration of lactation and samples assayed for fasting insulin and C-peptide (n = 543). The Brigham and Women’s Hospital Institutional Review Board and the Harvard T.H. Chan School of Public Health Human Subjects Committee Review Board approved the study protocol.

Exposure Assessments

Lactation history was obtained from three NHS II follow-up questionnaires. In 1993, participants were asked “how many months in total (all births combined) did you breastfeed?” with the following response options: did not breastfeed, <1, 1–3, 4–6, 7–11, 12–17, 18–23, 23–35, 36–47, ≥48 months, cannot remember. Similar questionnaires were sent in 1997 and 2003 to update and overwrite lactation information with the latest response. Lifetime duration of lactation was calculated from the sum of the number of months after each birth that the participant reported any breastfeeding. Duration of exclusive breastfeeding was similarly calculated using the reported timing of introduction of formula or solids after each birth.

Information on other potential risk factors, including medical, demographic, and reproductive histories, lifestyle practices, and body weight, were collected through NHS II biennial questionnaires. The validity of these assessments has been documented previously (22). Parity was defined as the number of pregnancies lasting >6 months and updated through follow-up questionnaires. Age at first birth was collected through the NHS II biennial questionnaire in 2007. To reflect the earliest available lifestyle information during reproductive years, lifestyle data collected in 1991 were used. Dietary intake was assessed using a validated semiquantitative food frequency questionnaire in 1991 (23,24). Diet quality was assessed using the Alternate Healthy Eating Index 2010 score, which was developed to determine scores for foods and nutrients most consistently associated with lower chronic disease risk (25). Physical activity was ascertained in 1991, and MET-hours per week was derived (26). As a surrogate prepregnancy BMI measure, BMI at age 18 years was calculated as self-reported weight (kg) at age 18 years divided by the square of height (m2). The previous validation study showed self-reported weights were highly correlated with measured weights (r = 0.97) (27).

Type 2 Diabetes Ascertainment

The baseline questionnaire and all biennial follow-up questionnaires asked participants about the incidence of physician-diagnosed diabetes. Participants who reported such a diagnosis received a supplementary questionnaire asking about symptoms, diagnostic tests, and treatment to confirm the diagnosis. The validity of the supplementary questionnaire for type 2 diabetes has been documented previously (28,29), in which self-reported diagnosis of diabetes was confirmed by medical records reviewed by an endocrinologist blinded to the supplementary questionnaire information for 61 of 62 (98%) participants randomly selected in the NHS.

The diagnosis was confirmed if at least one of the following was reported according to the National Diabetes Data Group criteria (30): 1) at least one symptom (excessive thirst, polyuria, weight loss, or hunger) plus fasting glucose ≥7.8 mmol/L or random glucose ≥11.1 mmol/L; 2) in the absence of symptoms, at least two elevated glucose concentrations on different occasions (fasting glucose >7.8 mmol/L, random glucose ≥11.1 mmol/L, and/or 2-h postload ≥11.1 mmol/L at an oral glucose tolerance test); or 3) treatment with insulin or oral hypoglycemic medication. For the cases identified after 1998, the revised American Diabetes Association criteria were applied using the fasting glucose cutoff of 7.0 mmol/L (31).

Biochemical Analysis

Blood sample collection was described in detail previously (21). Briefly, a phlebotomy kit and instructions for fasting blood collection were sent to participants in 2012–2014. Samples were returned via overnight shipping to a central laboratory where blood was processed according to standardized procedures and stored at −80°C. HbA1c was measured using a nonporous ion exchange high-performance liquid chromatograph assay (Tosoh Automated Analyzer HLC-723G8; Tosoh Bioscience, Inc., San Francisco, CA) (interassay coefficient of variation [CV] <1.2%). C-peptide concentrations were measured using C-peptide microELISA (Quansys Biosciences, Logan, UT) (interassay CV 10.0% at 3.6 ng/mL and 7.3% at 1.9 ng/mL). Insulin concentrations were measured using the cobas 6000 chemistry analyzer (Roche Diagnostics, Indianapolis, IN) (interassay CV 3.1% at 121.2 pmol/L and 3.1% at 377.9 pmol/L).

Statistical Analysis

Distributions of continuous variables were assessed for normality, and natural log transformations of skewed biomarkers were used in subsequent analyses. Descriptive statistics for continuous variables are summarized as mean ± SD, and categorical variables are summarized using proportions according to lactation duration categories.

Participants contributed to person-time from the date of the GDM diagnosis to the date of the type 2 diabetes diagnosis, death, or the end of follow-up, whichever came first. We used multivariable time-dependent Cox proportional hazards models to estimate hazard ratio (HR) and 95% CI, and the time scale for the left-truncated survival model was age (months). Model 1 was age adjusted. Model 2 was additionally adjusted for ethnicity (white/nonwhite), family history of diabetes (yes/no), parity, and age at first birth (<25, 25–29, 30–34, ≥35 years). Model 3 was additionally adjusted for ever smoking assessed in 1991 (yes/no), diet quality assessed in 1991 (tertiles), physical activity in 1991 (tertiles), and prepregnancy BMI (≤23, >23–25, >25–27, >27–30, >30 kg/m2). For age at first birth (1% missing), missing indicators were generated to treat missing as a separate category. Tests for trend were conducted by assigning a median value to each category and modeling this value as a continuous variable. General linear models were used to assess associations of lactation duration with glucose metabolic biomarkers among women free of type 2 diabetes at the follow-up blood draw, defined as HbA1c <6.5% (48 mmol/mol). Potential interactions were tested by adding an interaction term of lactation duration (continuous) with age (continuous), parity (continuous), primipara (yes/no), prepregnancy BMI (continuous), and age at index GDM diagnosis (continuous) with adjustment for covariates included in model 2.

For all statistical analyses, two-sided P < 0.05 was considered to be statistically significant. All data analyses were performed using SAS 9.4 software for UNIX (SAS Institute, Cary, NC).

Results

We documented 873 incident cases of type 2 diabetes among 4,372 women with a history of GDM during 87,411 person-years of follow-up. Women were a median age 31.8 (95% CI 25.2–40.2) years at the index GDM diagnosis and 49.8 (39.2–61.5) years at the type 2 diabetes diagnosis. The age-standardized characteristics of study participants are presented according to lifetime duration of lactation in Table 1.

View this table:
  • View inline
  • View popup
Table 1

Characteristics of NHS II participants according to lifetime duration of lactation (N = 4,372)

Lactation Duration and Type 2 Diabetes

HRs for developing type 2 diabetes are presented in Table 2 with models adjusting for other risk factors. A longer lifetime duration of lactation was associated with lower risk for type 2 diabetes (Table 2). When lactation was treated as a continuous variable per year increase, the association remained (HR 0.89 [95% CI 0.83–0.96]) with the model 3 adjustment. When model 3 was additionally adjusted for marital status (yes/no), the significant association remained (HR 1.05 [95% CI 0.82–1.34] for up to 6 months, 0.91 [0.71–1.15] for 6–12 months, 0.84 [0.67–1.06] for 12–24 months, and 0.73 [0.57–0.93] for >24 months compared with 0 months; P for trend = 0.004). There was no statistically significant effect modification in the association between lactation duration and type 2 diabetes by age, parity, primipara, prepregnancy BMI, or age at the index GDM diagnosis.

View this table:
  • View inline
  • View popup
Table 2

HR (95% CI) for type 2 diabetes among women with a history of GDM, according to lifetime duration of total lactation in NHS II (N = 4,372)

Similarly, a longer lifetime duration of exclusive lactation was associated with a lower risk for type 2 diabetes (Table 3).

View this table:
  • View inline
  • View popup
Table 3

HR (95% CI) for type 2 diabetes among women with a history of GDM, according to lifetime duration of exclusive lactation in NHS II (N = 4,006)

Lactation Duration and Biomarkers of Glucose Metabolism Among Women Free of Type 2 Diabetes

Multiple regression models were constructed to assess whether duration of lactation was associated with glucose metabolic biomarkers among women who provided blood samples in 2012–2014 (Table 4). At the follow-up blood collection, women were a median age of 58.2 (95% CI 51–65) years and 26.3 (95% CI 15.7–34.1) years since the GDM index pregnancy. Among women free of type 2 diabetes at the blood collection, a longer lactation duration was significantly associated with HbA1c, fasting insulin, and C-peptides (Table 4).

View this table:
  • View inline
  • View popup
Table 4

Least-squares mean (95% CI) biomarker concentrations of glucose metabolic biomarkers according to lifetime duration of lactation among women free of diabetes (HbA1c <6.5% [48 mmol/mol]) with a history of GDM (n = 543)

Conclusions

Among 4,372 women with a history of GDM during 87,411 person-years of follow-up, longer lifetime lactation duration was associated with a lower risk of type 2 diabetes after adjustment for age at first birth, ethnicity, family history of diabetes, parity, smoking, diet quality, physical activity, and prepregnancy BMI. Further, longer lifetime duration of lactation was associated with lower concentrations of HbA1c, fasting insulin, and C-peptide among middle-aged women without type 2 diabetes.

Our incident type 2 diabetes results are in general similar to recent reports from prospective studies in the U.S. and Europe (14–16). In 155 women with a history of GDM participating in the Coronary Artery Risk Development in Young Adults (CARDIA) study (14), lactation duration had a graded inverse association with diabetes incidence. Although longer duration of lactation was associated with lower risk for type 2 diabetes in the NHS and NHS II (13), the association was not statistically significant in a sensitivity analysis among women with a history of GDM in the previous analysis of NHS II using up to 2001 follow-up. Having follow-up data up to 2017 enabled us to perform updated analyses among women with a history of GDM in NHS II. In these updated analyses monitoring women up to ages in their early-60s, as opposed to the earlier report of monitoring up to their mid-40s, we observed a significant association of longer lifetime duration of lactation with lower risk for type 2 diabetes among women with a history of GDM. Since U.S. women between ages mid-40s and early-60s experience a sharp increase in the incidence of type 2 diabetes (32), this increased power is likely to have contributed to the detection of a significant association of longer lifetime duration of lactation with lower risk for type 2 diabetes among women with a history of GDM.

Previously, the favorable recovery of postpartum glucose homeostasis has been documented among women who adopt breastfeeding behavior in the early postpartum period (18,19,33). In a clinical study among 26 women with recent GDM (14 breastfeeding and 12 nonbreastfeeding) at 3 months postpartum, the disposition index, which is the product of insulin sensitivity times the amount of insulin secreted in response to blood glucose concentrations, was higher in the breastfeeding group (19). However, whether this early favorable recovery might have a sustained long-term impact on glucose homeostasis was unclear. In a study with 3-year postpartum follow-up, women who breastfed for longer tended to have lower fasting insulin concentrations, although the association did not reach statistical significance after multiple adjustment (34); however, these women in their 30s might recover their glucose homeostasis to some extent by 3 years postpartum. We have performed biochemical analysis of fasting insulin and C-peptide concentrations in women at a median age of 58 years to assess the association between earlier lactation behavior and glucose metabolic biomarkers later in life. We report the associations of longer lactation duration with lower fasting insulin and C-peptide concentrations as indicators of insulin action in middle-aged women with a history of GDM and free of type 2 diabetes at follow-up. Although fasting plasma insulin and C-peptide concentrations to some minor extent are influenced by pancreatic insulin secretion capacity, there is consensus that fasting plasma insulin and C-peptide predominantly are a measure of insulin resistance in individuals without severe diabetes and β-cell defects.

This study has several notable strengths. It is the largest long-term prospective investigation of lactation, biomarkers of glucose metabolism, and type 2 diabetes prevention among women with a history of GDM to date, allowing assessment of long-term diabetes risk and glucose metabolic biomarkers specific to these high-risk women.

However, the study has several limitations. First, our study participants were nurses of primarily European ancestry; therefore, further investigations targeting specific populations of more diverse socioeconomic status are warranted to develop optimal prevention routes.

Second, our blood samples were shipped overnight after collection, then processed, and stored for 1–3 years at −80°C before biochemical analyses were performed. The process might have introduced molecular degradation, although stability of these biomarkers after delay in processing and long-term storage has been documented previously (35).

Third, we were not able to obtain valid measure of fasting plasma concentrations of glucose in these samples because of overnight shipping collection methods used; therefore, we were unable to assess HOMA estimates. However, fasting insulin was used as a surrogate marker for insulin resistance because insulin resistance and hyperinsulinemia rarely exist in isolation in a diabetes-free population (36). Further, the consistent association between lactation duration and C-peptide confirms that its association is unlikely influenced by exogenous insulin.

Fourth, the observed benefits of lactation may have been confounded by other healthful behaviors, although we attempted to account for these confounders through statistical adjustment of regression models.

Fifth, we did not have precise measurements of pregnancy and early postpartum clinical parameters, including weight gain and energy expenditure. Since gestational and postpartum weight gain (37), energy expenditure during lactation (38), and other pregnancy and postpartum clinical parameters including biochemical measurements and detailed fetus information may be involved in the mechanism behind the observed associations, we recommend carefully designed and controlled future studies to determine the causality and mechanisms and to examine life stage–specific questions.

In summary, longer lifetime duration of lactation is associated with incident type 2 diabetes and a favorable glucose metabolic biomarker profile among middle-aged women with a history of GDM. Prolonged breastfeeding should be encouraged during pregnancy, especially among women with GDM who are at increased risk for experiencing breastfeeding challenges in early postpartum (17) in addition to being at higher risk for type 2 diabetes progression later in life (6,7). It is furthermore important to understand the underlying mechanisms and additional potential benefits on diabetes complications, comorbidity, and mortality.

Article Information

Funding. This study was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (contract no. HHSN275201000020C), National Institutes of Health. The Nurses’ Health Study II was funded by National Institutes of Health research grants DK-112940, CA-50385, P30-DK-46200, U01-CA-176726, R01-CA-67262, and U01-HL-145386-01. S.H.L. was supported by National Institute of General Medical Sciences grant P20-GM-109036 from of the National Institutes of Health.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. S.H.L. designed and performed the analysis and wrote the manuscript. S.H.L. and C.Z. had primary responsibility for final content. J.E.C., M.L., W.B., S.N.H., P.L.W., J.R.-E., S.O., A.V., P.D., L.G.G., J.L.M., and F.B.H. read and approved the final manuscript and contributed in revising the manuscript critically for important intellectual content. F.B.H. provided essential materials including access to databases. C.Z. designed and provided oversight of the Diabetes & Women’s Health Study. S.H.L. and C.Z. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. Parts of this study were presented in abstract form at the 16th Symposium of the International Diabetes Epidemiology Group, Seoul, South Korea, 29 November–2 December 2019.

  • Received November 6, 2019.
  • Accepted January 27, 2020.
  • © 2020 by the American Diabetes Association.
https://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Butte NF
    . Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000;71(Suppl.):1256S–1261S
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Catalano PM,
    2. Tyzbir ED,
    3. Wolfe RR,
    4. Roman NM,
    5. Amini SB,
    6. Sims EA
    . Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol 1992;167:913–919
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Di Cianni G,
    2. Miccoli R,
    3. Volpe L,
    4. Lencioni C,
    5. Del Prato S
    . Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003;19:259–270
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Reece EA,
    2. Leguizamón G,
    3. Wiznitzer A
    . Gestational diabetes: the need for a common ground. Lancet 2009;373:1789–1797
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. DeSisto CL,
    2. Kim SY,
    3. Sharma AJ
    . Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014;11:E104
    OpenUrlCrossRefPubMed
  6. ↵
    1. Kim C,
    2. Newton KM,
    3. Knopp RH
    . Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862–1868
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Lawrence JM,
    2. Contreras R,
    3. Chen W,
    4. Sacks DA
    . Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31:899–904
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Ley SH
    . Role of lactation in cardiometabolic health consequences. J Womens Health (Larchmt) 2019;28:3–4
    OpenUrl
  9. ↵
    1. Ip S,
    2. Chung M,
    3. Raman G, et al
    . Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 2007;153:1–186
    OpenUrlPubMed
  10. ↵
    1. Jäger S,
    2. Jacobs S,
    3. Kröger J, et al
    . Breast-feeding and maternal risk of type 2 diabetes: a prospective study and meta-analysis. Diabetologia 2014;57:1355–1365
    OpenUrlCrossRefPubMed
    1. Aune D,
    2. Norat T,
    3. Romundstad P,
    4. Vatten LJ
    . Breastfeeding and the maternal risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis 2014;24:107–115
    OpenUrlCrossRefPubMed
  11. ↵
    1. Rameez RM,
    2. Sadana D,
    3. Kaur S, et al
    . Association of maternal lactation with diabetes and hypertension: a systematic review and meta-analysis. JAMA Netw Open 2019;2:e1913401
    OpenUrl
  12. ↵
    1. Stuebe AM,
    2. Rich-Edwards JW,
    3. Willett WC,
    4. Manson JE,
    5. Michels KB
    . Duration of lactation and incidence of type 2 diabetes. JAMA 2005;294:2601–2610
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Gunderson EP,
    2. Lewis CE,
    3. Lin Y, et al
    . Lactation duration and progression to diabetes in women across the childbearing years: the 30-year CARDIA study. JAMA Intern Med 2018;178:328–337
    OpenUrl
    1. Gunderson EP,
    2. Hurston SR,
    3. Ning X, et al.; Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy Investigators
    . Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study. Ann Intern Med 2015;163:889–898
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ziegler A-G,
    2. Wallner M,
    3. Kaiser I, et al
    . Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes 2012;61:3167–3171
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Hartmann P,
    2. Cregan M
    . Lactogenesis and the effects of insulin-dependent diabetes mellitus and prematurity. J Nutr 2001;131:3016S–3020S
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Kjos SL,
    2. Henry O,
    3. Lee RM,
    4. Buchanan TA,
    5. Mishell DR Jr
    . The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 1993;82:451–455
    OpenUrlPubMedWeb of Science
  17. ↵
    1. McManus RM,
    2. Cunningham I,
    3. Watson A,
    4. Harker L,
    5. Finegood DT
    . Beta-cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism 2001;50:715–719
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Solomon CG,
    2. Willett WC,
    3. Carey VJ, et al
    . A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078–1083
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Zhang C,
    2. Olsen SF,
    3. Hinkle SN, et al.; Diabetes & Women’s Health Study Team
    . Diabetes & Women’s Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark. BMJ Open 2019;9:e025517
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Colditz GA,
    2. Martin P,
    3. Stampfer MJ, et al
    . Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894–900
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Yuan C,
    2. Spiegelman D,
    3. Rimm EB, et al
    . Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol 2017;185:570–584
    OpenUrlPubMed
  22. ↵
    1. Yuan C,
    2. Spiegelman D,
    3. Rimm EB, et al
    . Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women. Am J Epidemiol 2018;187:1051–1063
    OpenUrl
  23. ↵
    1. Chiuve SE,
    2. Fung TT,
    3. Rimm EB, et al
    . Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 2012;142:1009–1018
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Wolf AM,
    2. Hunter DJ,
    3. Colditz GA, et al
    . Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994;23:991–999
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Rimm EB,
    2. Stampfer MJ,
    3. Colditz GA,
    4. Chute CG,
    5. Litin LB,
    6. Willett WC
    . Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466–473
    OpenUrlCrossRefPubMed
  26. ↵
    1. Manson JE,
    2. Rimm EB,
    3. Stampfer MJ, et al
    . Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991;338:774–778
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Hu FB,
    2. Leitzmann MF,
    3. Stampfer MJ,
    4. Colditz GA,
    5. Willett WC,
    6. Rimm EB
    . Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001;161:1542–1548
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. National Diabetes Data Group
    . Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039–1057
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. American Diabetes Association
    . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183–1197
    OpenUrlFREE Full Text
  30. ↵
    1. Centers for Disease Control and Prevention
    . National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States [Internet], 2017. Available from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed 25 November 2019
  31. ↵
    1. Stuebe AM,
    2. Schwarz EB
    . The risks and benefits of infant feeding practices for women and their children. J Perinatol 2010;30:155–162
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Stuebe AM,
    2. Kleinman K,
    3. Gillman MW,
    4. Rifas-Shiman SL,
    5. Gunderson EP,
    6. Rich-Edwards J
    . Duration of lactation and maternal metabolism at 3 years postpartum. J Womens Health (Larchmt) 2010;19:941–950
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Gislefoss RE,
    2. Grimsrud TK,
    3. Mørkrid L
    . Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009;47:596–603
    OpenUrlCrossRefPubMed
  34. ↵
    1. Kim SH,
    2. Reaven GM
    . Insulin resistance and hyperinsulinemia: you can’t have one without the other. Diabetes Care 2008;31:1433–1438
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Baker JL,
    2. Gamborg M,
    3. Heitmann BL,
    4. Lissner L,
    5. Sørensen TI,
    6. Rasmussen KM
    . Breastfeeding reduces postpartum weight retention. Am J Clin Nutr 2008;88:1543–1551
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Dewey KG
    . Energy and protein requirements during lactation. Annu Rev Nutr 1997;17:19–36
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 43 (4)

In this Issue

April 2020, 43(4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus
Sylvia H. Ley, Jorge E. Chavarro, Mengying Li, Wei Bao, Stefanie N. Hinkle, Pandora L. Wander, Janet Rich-Edwards, Sjurdur Olsen, Allan Vaag, Peter Damm, Louise G. Grunnet, James L. Mills, Frank B. Hu, Cuilin Zhang
Diabetes Care Apr 2020, 43 (4) 793-798; DOI: 10.2337/dc19-2237

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus
Sylvia H. Ley, Jorge E. Chavarro, Mengying Li, Wei Bao, Stefanie N. Hinkle, Pandora L. Wander, Janet Rich-Edwards, Sjurdur Olsen, Allan Vaag, Peter Damm, Louise G. Grunnet, James L. Mills, Frank B. Hu, Cuilin Zhang
Diabetes Care Apr 2020, 43 (4) 793-798; DOI: 10.2337/dc19-2237
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal Women
  • Trajectories of Childhood Adversity and Type 1 Diabetes: A Nationwide Study of One Million Children
  • Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy
Show more Epidemiology/Health Services Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.